Department of Defense

Improper pressure from President Donald Trump, who said he wanted to "screw Amazon," contributed to the decision to deny Amazon.com Inc.'s (NASDAQ: AMZN) Amazon Web Services a $10 billion defense contract, the company alleges in a newly unsealed complaint protesting the award. The...

The head of the Defense Department on Friday said there was no bias in the agency’s awarding of an enormous $10 billion cloud computing contract known as JEDI to Microsoft Corporation (NASDAQ: MSFT). But for investors and analysts trying to figure out which computing companies may have the...

Amazon.com, Inc. (NASDAQ: AMZN) is considering its legal options to protest the Pentagon's decision to grant a $10-billion cloud computing contract to Microsoft Corporation (NASDAQ: MSFT), Reuters reported Monday.  What Happened The Department of Defense awarded the JEDI, or...

Tech giant Oracle Corporation (NYSE: ORCL) was eliminated from a contract with the U.S. government in April and has lost a legal challenge it mounted over the decision, Bloomberg reported Friday. The Pentagon eliminated Oracle from a four-way bidding process with a $10-billion cloud contract...

Whether it’s fair or not, shares of a few major U.S. multinational companies are often seen as bellwethers for the progress of U.S./China trade negotiations. Boeing Co (NYSE: BA)—which reports Q4 earnings before the market open on Wednesday and counts China among its major...

Earlier this year, the Department of Defense announced a winner-take-all competition in order to select a cloud computing company to host its sensitive information.  Some of the initial contenders included Amazon.com, Inc. (NASDAQ: AMZN), Microsoft Corporation (NASDAQ: MSFT), Oracle...

Shares of Nano Dimension (NASDAQ: NNDM) gained more than 100 percent in value Monday morning in reaction to an encouraging development with the Department of Defense and other federal agencies.  What Happened Israel-based Nano Dimension said Monday that its American subsidiary achieved...

Pluristem Therapeutics Inc. (NASDAQ: PSTI), which develops placenta-based cell therapy products, announced Monday that the FDA cleared an investigational new drug application for PLX-R18 cell therapy to treat acute radiation syndrome. Pluristem shares were rallying 7.26 percent Monday afternoon...

A group of researchers are warning the world about weaponizing artificial intelligence and robotics, but that machine-learning genie may already be out of the bottle. There are clear signs that the United States is already engaged in an AI arms race with China and Russia to develop weapons systems...

Shares of aerospace components manufacturer TransDigm Group Incorporated (NYSE: TDG) were getting hammered on Tuesday afternoon after Representative Ro Khanna, a U.S. representative for California's 17th congressional district, requested an investigation into the company is launched. In a...

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is a micro-cap company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain in medically supervised settings. What’s particularly interesting here is that the development of its lead product...

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is a micro-cap company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain in medically supervised settings. Benzinga recently learned that the U.S. Department of Defense (DoD) had funded the...

Goldman Sachs’ Noah Poponak views the defense sector as attractive and Lockheed Martin Corporation (NYSE: LMT) as “the bellwether and owns one of the Pentagon’s fastest growing programs in the F-35.” Poponak reinitiated coverage of the company with a Neutral rating and a...